The Combination of Trametinib, a MEK Inhibitor, and Temsirolimus, an mTOR Inhibitor, Radiosensitizes Lung Cancer CellsSeo Yun Kim, Cheol Hyeon Kim|Anticancer Research|2021Cited by 10